Novaluron, also known as Repaglinide, is a glargine-type hypoglycemic drug, which belongs to insulinotropic agents, and plays a hypoglycemic role by promoting insulin secretion, so Novaluron can only be applied to patients with type 2 diabetes mellitus who have certain pancreatic β-cell function. The dosage of Novaluron is as follows: First, Novaluron is a short-acting oral hypoglycemic agent, with fast onset of action, short duration of action, and better simulation of physiological insulin secretion, so it must be taken orally before three times a day. Second, Novaluron by promoting insulin play a role, when the diet is not regular or too large a dose of medication, hypoglycemia may occur, so the dose of Novaluron need to be based on the degree of elevated blood glucose, under the guidance of a doctor. Third, Novaluron can be used in combination with oral drugs such as biguanide preparations, glucosidase inhibitors, insulin sensitizers, and basal insulin. Fourth, in the process of taking Novaluron, should pay attention to monitoring blood glucose, regular diet to avoid serious hypoglycemia.